I think investors will look kindly on costs related to promotion of cardiocel and development of the vaccines providing the cardiocel sales show promising growth. As I said previously, once the brand gets more widely accepted, market share will grow and revenue will be huge.
need good news in annual report, page-8
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.15 |
Change
0.640(4.74%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.15 | $13.35 | $291.9K | 21.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1167 | $13.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.15 | 1162 | 2 |
View Market Depth
| Last trade - 15.49pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |